These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20350005)

  • 1. Identification of phenylsulfone-substituted quinoxaline (WYE-672) as a tissue selective liver X-receptor (LXR) agonist.
    Hu B; Unwalla RJ; Goljer I; Jetter JW; Quinet EM; Berrodin TJ; Basso MD; Feingold IB; Nilsson AG; Wilhelmsson A; Evans MJ; Wrobel JE
    J Med Chem; 2010 Apr; 53(8):3296-304. PubMed ID: 20350005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver X receptor (LXR) partial agonists: biaryl pyrazoles and imidazoles displaying a preference for LXRβ.
    Kick E; Martin R; Xie Y; Flatt B; Schweiger E; Wang TL; Busch B; Nyman M; Gu XH; Yan G; Wagner B; Nanao M; Nguyen L; Stout T; Plonowski A; Schulman I; Ostrowski J; Kirchgessner T; Wexler R; Mohan R
    Bioorg Med Chem Lett; 2015 Jan; 25(2):372-7. PubMed ID: 25435151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quinoline-3-carboxamide containing sulfones as liver X receptor (LXR) agonists with binding selectivity for LXRbeta and low blood-brain penetration.
    Hu B; Bernotas R; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wilhelmsson A; Nambi P; Evans M; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):689-93. PubMed ID: 19962892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different roles of liver X receptor alpha and beta in lipid metabolism: effects of an alpha-selective and a dual agonist in mice deficient in each subtype.
    Lund EG; Peterson LB; Adams AD; Lam MH; Burton CA; Chin J; Guo Q; Huang S; Latham M; Lopez JC; Menke JG; Milot DP; Mitnaul LJ; Rex-Rabe SE; Rosa RL; Tian JY; Wright SD; Sparrow CP
    Biochem Pharmacol; 2006 Feb; 71(4):453-63. PubMed ID: 16325781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 4-(3-biaryl)quinoline sulfones as potent liver X receptor agonists.
    Ullrich JW; Morris R; Bernotas RC; Travins JM; Jetter J; Unwalla R; Quinet E; Nambi P; Feingold I; Huselton C; Enroth C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 May; 20(9):2903-7. PubMed ID: 20382019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor (LXR)-beta regulation in LXRalpha-deficient mice: implications for therapeutic targeting.
    Quinet EM; Savio DA; Halpern AR; Chen L; Schuster GU; Gustafsson JA; Basso MD; Nambi P
    Mol Pharmacol; 2006 Oct; 70(4):1340-9. PubMed ID: 16825483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of a novel liver X receptor agonist with partial LXRα activity and a favorable window in nonhuman primates.
    Kirchgessner TG; Martin R; Sleph P; Grimm D; Liu X; Lupisella J; Smalley J; Narayanan R; Xie Y; Ostrowski J; Cantor GH; Mohan R; Kick E
    J Pharmacol Exp Ther; 2015 Feb; 352(2):305-14. PubMed ID: 25467132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indazole-based liver X receptor (LXR) modulators with maintained atherosclerotic lesion reduction activity but diminished stimulation of hepatic triglyceride synthesis.
    Wrobel J; Steffan R; Bowen SM; Magolda R; Matelan E; Unwalla R; Basso M; Clerin V; Gardell SJ; Nambi P; Quinet E; Reminick JI; Vlasuk GP; Wang S; Feingold I; Huselton C; Bonn T; Farnegardh M; Hansson T; Nilsson AG; Wilhelmsson A; Zamaratski E; Evans MJ
    J Med Chem; 2008 Nov; 51(22):7161-8. PubMed ID: 18973288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of phenyl acetic acid substituted quinolines as novel liver X receptor agonists for the treatment of atherosclerosis.
    Hu B; Collini M; Unwalla R; Miller C; Singhaus R; Quinet E; Savio D; Halpern A; Basso M; Keith J; Clerin V; Chen L; Resmini C; Liu QY; Feingold I; Huselton C; Azam F; Farnegardh M; Enroth C; Bonn T; Goos-Nilsson A; Wilhelmsson A; Nambi P; Wrobel J
    J Med Chem; 2006 Oct; 49(21):6151-4. PubMed ID: 17034119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-(3-Aryloxyaryl)quinoline sulfones are potent liver X receptor agonists.
    Bernotas RC; Singhaus RR; Kaufman DH; Travins JM; Ullrich JW; Unwalla R; Quinet E; Evans M; Nambi P; Olland A; Kauppi B; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(1):209-12. PubMed ID: 19932617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-(3-Aryloxyaryl)benzimidazole sulfones are liver X receptor agonists.
    Travins JM; Bernotas RC; Kaufman DH; Quinet E; Nambi P; Feingold I; Huselton C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):526-30. PubMed ID: 20006495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-Acylthiadiazolines, a new class of liver X receptor agonists with selectivity for LXRbeta.
    Molteni V; Li X; Nabakka J; Liang F; Wityak J; Koder A; Vargas L; Romeo R; Mitro N; Mak PA; Seidel HM; Haslam JA; Chow D; Tuntland T; Spalding TA; Brock A; Bradley M; Castrillo A; Tontonoz P; Saez E
    J Med Chem; 2007 Aug; 50(17):4255-9. PubMed ID: 17665897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tributyltin chloride induces ABCA1 expression and apolipoprotein A-I-mediated cellular cholesterol efflux by activating LXRα/RXR.
    Cui H; Okuhira K; Ohoka N; Naito M; Kagechika H; Hirose A; Nishimaki-Mogami T
    Biochem Pharmacol; 2011 Mar; 81(6):819-24. PubMed ID: 21219878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a selective agonist for liver X receptor α (LXRα) via screening of a synthetic compound library.
    Li N; Xu Y; Feng T; Liu C; Li Y; Wang X; Si S
    J Biomol Screen; 2014 Apr; 19(4):566-74. PubMed ID: 24334278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-(3-Aryloxyaryl)imidazo[1,2-a]pyridine sulfones as liver X receptor agonists.
    Singhaus RR; Bernotas RC; Steffan R; Matelan E; Quinet E; Nambi P; Feingold I; Huselton C; Wilhelmsson A; Goos-Nilsson A; Wrobel J
    Bioorg Med Chem Lett; 2010 Jan; 20(2):521-5. PubMed ID: 20005711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.
    Hu X; Steffensen KR; Jiang ZY; Parini P; Gustafsson JÅ; Gåfvels M; Eggertsen G
    J Intern Med; 2012 Nov; 272(5):452-64. PubMed ID: 22329358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quercetin up-regulates expressions of peroxisome proliferator-activated receptor γ, liver X receptor α, and ATP binding cassette transporter A1 genes and increases cholesterol efflux in human macrophage cell line.
    Lee SM; Moon J; Cho Y; Chung JH; Shin MJ
    Nutr Res; 2013 Feb; 33(2):136-43. PubMed ID: 23399664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists.
    Nomura S; Endo-Umeda K; Makishima M; Hashimoto Y; Ishikawa M
    ChemMedChem; 2016 Oct; 11(20):2347-2360. PubMed ID: 27690261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propofol up-regulates expression of ABCA1, ABCG1, and SR-B1 through the PPARγ/LXRα signaling pathway in THP-1 macrophage-derived foam cells.
    Ma X; Li SF; Qin ZS; Ye J; Zhao ZL; Fang HH; Yao ZW; Gu MN; Hu YW
    Cardiovasc Pathol; 2015; 24(4):230-5. PubMed ID: 25600616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.
    Hu B; Unwalla R; Collini M; Quinet E; Feingold I; Goos-Nilsson A; Wihelmsson A; Nambi P; Wrobel J
    Bioorg Med Chem; 2009 May; 17(10):3519-27. PubMed ID: 19394832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.